KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gilead Sciences (GILD) Shares Outstanding (Weighted Average) (2016 - 2026)

Gilead Sciences filings provide 17 years of Shares Outstanding (Weighted Average) readings, the most recent being $1.2 billion for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.24% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 0.24% change, with the full-year FY2025 number at $1.2 billion, changed 0.24% from a year prior.
  • Shares Outstanding (Weighted Average) hit $1.2 billion in Q4 2025 for Gilead Sciences, roughly flat from $1.2 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q1 2021 to a low of $1.2 billion in Q4 2025.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $1.2 billion (2023), compared with a mean of $1.3 billion.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 0.08% in 2021 and later dropped 0.56% in 2023.
  • Gilead Sciences' Shares Outstanding (Weighted Average) stood at $1.3 billion in 2021, then fell by 0.08% to $1.3 billion in 2022, then dropped by 0.56% to $1.2 billion in 2023, then dropped by 0.08% to $1.2 billion in 2024, then fell by 0.24% to $1.2 billion in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025) per Business Quant data.